Receptors for myelin inhibitors: Structures and therapeutic opportunities
Authors:
- Ying GaoYGYing Gao
- Kangwen DengKDKangwen Deng
- Gareth WilliamsGWGareth Williams
- Patrick DohertyPDPatrick Doherty
- Frank S. WalshFWFrank S. Walsh
- 1 January 2010
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 43 (1) , 1-14
Abstract
No abstract availableKeywords
This publication has 192 references indexed in Scilit:
- Assessment of functional recovery and axonal sprouting in oligodendrocyte-myelin glycoprotein (OMgp) null mice after spinal cord injuryMolecular and Cellular Neuroscience, 2008
- A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in miceExperimental Neurology, 2008
- Regulation of CNS synapses by neuronal MHC class IProceedings of the National Academy of Sciences, 2007
- Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d)Proceedings of the National Academy of Sciences, 2006
- Delayed Nogo receptor therapy improves recovery from spinal cord contusionAnnals of Neurology, 2006
- Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cellsProceedings of the National Academy of Sciences, 2006
- Sialidase enhances spinal axon outgrowth in vivoProceedings of the National Academy of Sciences, 2006
- Dying-back oligodendrogliopathy: A late sequel of myelin-associated glycoprotein deficiencyGlia, 1997
- Gangliosides -- A new therapeutic agent against stroke and Alzheimer's diseaseLife Sciences, 1994
- Schwann cells infected with a recombinant retrovirus expressing myelin-associated glycoprotein antisense RNA do not form myelinNeuron, 1991